[breadcrumb_custom]

BSX’s Financial Health: Exploring Boston Scientific Corp.’s Debt-to-Equity Ratio of 1.79

Boston Scientific Corp. (BSX) currently has a stock price of $54.67. The stock saw a sharp increase in the last trading session, hitting a high of $54.90 after opening at $53.95. The lowest recorded price for the day was $53.56 before it closed at $53.85.

Boston Scientific Corp.’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $55.38 on 09/20/23, with the lowest value being $41.93 on 11/17/22.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.

Sponsored

52-week price history of BSX Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Boston Scientific Corp.’s current trading price is -1.28% away from its 52-week high, while its distance from the 52-week low is 30.38%. The stock’s price range for this period has remained between $41.93 and $55.38. The Healthcare sector company’s shares managed to surpass a trading volume of around 10.88 million for the day, which was noticeably higher compared to the shares’ average daily volume of 8.51 million over the last three months.

Financial Performance and Market Capitalization

Boston Scientific Corp. (BSX) has experienced a quarterly rise of 8.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 80.09B and boasts a workforce of 45000 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 52.16, with a change in price of +1.18. Similarly, Boston Scientific Corp. recorded 7,876,829 in trading volume during the last 100 days, posting a change of +2.21%.

BSX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BSX stands at 0.49. Similarly, the long-term debt-to-equity ratio is also 0.47.

BSX Stock Stochastic Average

As of today, the raw stochastic average of Boston Scientific Corp. over the past 50 days is 89.90%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 96.00%. Additionally, the Stochastic %K and %D values for the company were 89.49% and 83.79%, respectively, over the past 20 days.

BSX Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 18.15%.However, over the last six months, we can see a weaker performance of 2.30%. Over the last 30 days, the price of BSX has fallen by 7.81%. And in the last five days, it has surged by 6.30%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts